Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Becton Dickinson and Company (BDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 43,921,012
  • Shares Outstanding, K 227,570
  • Annual Sales, $ 12,483 M
  • Annual Income, $ 977,000 K
  • 36-Month Beta 1.06
  • Price/Sales 3.57
  • Price/Cash Flow 13.96
  • Price/Book 3.53

Price Performance

See More
Period Period Low Period High Performance
1-Month
192.65 +0.43%
on 09/20/17
204.86 -5.56%
on 09/11/17
-4.21 (-2.13%)
since 08/18/17
3-Month
192.02 +0.76%
on 06/29/17
206.63 -6.36%
on 07/25/17
-0.98 (-0.50%)
since 06/20/17
52-Week
161.29 +19.96%
on 12/07/16
206.63 -6.36%
on 07/25/17
+17.59 (+10.00%)
since 09/20/16

Most Recent Stories

More News
Becton, Dickinson Ultra-Fine Needle to Improve Diabetic Care

Becton, Dickinson and Company's (BDX) latest micro pen needle will enhance the scope of its Diabetic Care unit.

EW : 111.01 (-0.24%)
AMED : 50.80 (+0.91%)
BDX : 193.10 (+0.05%)
IDXX : 158.03 (-1.56%)
BD and Euroclone Announce Development and Global Distribution Agreement for Tests to Detect Emerging Sexually-Transmitted Pathogens

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Euroclone (Euroclone Diagnostica Srl) today announced a development and global distribution agreement for...

BDX : 193.10 (+0.05%)
BD Introduces New 6mm Pen Needle for Injection Pens

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the introduction of the BD Ultra-Fine(TM) micro pen needle 6mm x 32G for use with leading pen...

BDX : 193.10 (+0.05%)
Becton, Dickinson's (BCR) C.R. Bard Buyout Plans Bode Well

Becton, Dickinson and Company's (BDX) steady move toward the pending acquisition of C.R. Bard will lend it a leading position in the healthcare domain.

BCR : 318.29 (+0.06%)
EW : 111.01 (-0.24%)
LNTH : 17.25 (+0.87%)
BDX : 193.10 (+0.05%)
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of BD Rhapsody, a platform for single cell analysis with the ability to detect rare...

BDX : 193.10 (+0.05%)
The Zacks Analyst Blog Highlights: Home Depot, Aetna, Dickinson, Kellogg and FirstEnergy

The Zacks Analyst Blog Highlights: Home Depot, Aetna, Dickinson, Kellogg and FirstEnergy

AET : 154.29 (-1.12%)
BDX : 193.10 (+0.05%)
K : 64.50 (-2.08%)
HD : 158.40 (+0.47%)
FE : 31.15 (-0.70%)
Top Analyst Reports for Home Depot, Aetna & Becton, Dickinson

Top Analyst Reports for Home Depot, Aetna & Becton, Dickinson

AET : 154.29 (-1.12%)
BDX : 193.10 (+0.05%)
CAG : 33.47 (-2.05%)
K : 64.50 (-2.08%)
HD : 158.40 (+0.47%)
FE : 31.15 (-0.70%)
BD to Present at the Morgan Stanley Global Healthcare Conference 2017

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Morgan Stanley Global Healthcare Conference 2017 on Tuesday, September...

BDX : 193.10 (+0.05%)
Dividend Coverage: This Medical Tech Company has Raised Dividend for 45 Consecutive Years; Will Trade Ex-Dividend on September 07, 2017

LONDON, UK / ACCESSWIRE / September 6, 2017 / Pro-Trader Daily takes a closer look at Becton, Dickinson and Co. (NYSE: BDX) as the Company's stock will begin trading ex-dividend on September 07, 2017....

BDX : 193.10 (+0.05%)
Medical Supplies Stock Performance Review -- Integra LifeSciences, Antares Pharma, Becton, Dickinson and Co., and Waters

If you want a Stock Review on IART, ATRS, BDX, or WAT then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. IBISWorld reported that, over the five...

BDX : 193.10 (+0.05%)
IART : 48.52 (-3.06%)
ATRS : 2.84 (-3.40%)
WAT : 181.73 (-1.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BD's operations consist of three worldwide business segments: Medical Systems, Biosciences,...

See More

Support & Resistance

2nd Resistance Point 198.01
1st Resistance Point 195.50
Last Price 193.33
1st Support Level 191.59
2nd Support Level 190.19

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.